Life sciences consulting firm Clarkston Consulting said it has entered into a collaboration deal with 4G Clinical, which specializes in randomization and trial supply management (RTSM).
Under the agreement, the two firms said they look to create a comprehensive client experience as the life sciences industry undergoes transformational shifts in clinical operations. The two will also co-author industry reports and white papers on trends, drivers and strategies that affect clinical trial professionals.
Financial terms of the deal weren’t disclosed.
“As clinical trial complexity increases, the underlying technologies and capabilities that support the journey of a drug to market must evolve with it,” Dave Kelleher, 4G’s chief executive, said in a statement. The partnership with Clarkston will provide innovative capabilities and enable “better outcomes for the patient and the business,” he added.
RTSM systems support the randomization of patients into different arms of a trial and the supply of study drugs to sites. The technology has evolved from the phone-based systems of the 1990s, known by the abbreviation IVRS, to the web-based platforms in use today.
4G’s competitors include trial technology powerhouses like Medidata and Parexel.